Literature DB >> 19006116

Gender differences on brachial flow-mediated dilation and carotid intima-media thickness for prediction of spontaneous cardiovascular events.

Rui Hu1, Wei-Qun Wang, Chu-Pak Lau, Hung-Fat Tse.   

Abstract

BACKGROUND: Impaired brachial flow-mediated dilation (FMD) and increased carotid intima-media thickness (IMT) are associated with increased risk of cardiovascular events.
METHODS: We measured brachial FMD and a mean of 12 sites maximum carotid IMT (mmIMT) in 279 patients (mean age 62 +/- 12 y; 163 men) admitted for coronary angiography due to chest pain. HYPOTHESIS: There are gender differences in the predictive values of FMD and IMT for cardiovascular events.
RESULTS: Univariable analysis showed that impaired FMD (p < 0.001), but not increased mmIMT (p = 0.056), significantly predicted spontaneous cardiovascular events. After adjusting for the extent of coronary artery disease (CAD) and other clinical variables, age (heart rate [HR] 1.05, 95% confidence interval [CI]: 1.01-1.09, p = 0.017) and FMD (HR 0.85, 95% CI: 0.75-0.97, p = 0.012) were independent predictors for cardiovascular events. A total of 148 (53%) patients had CAD (> or =50% diameter stenosis). Over a median follow-up of 16 mo, 36 (12.9%) patients experienced spontaneous cardiovascular events (cardiovascular death, stroke, acute myocardial infarction [MI], unstable angina pectoris, and congestive heart failure [HF]). Women were more likely than men to develop cardiovascular events in patients without significant CAD (11.9% versus 1.6%, odds ratio [OR] = 8.54, p = 0.033), but not in those patients with CAD (20.4 % versus 17.2%, OR = 1.24, p = 0.66). Moreover, women accounted for 8 (88.9%) events in non-CAD patients. Furthermore, impaired FMD predicted the occurrence of cardiovascular events in both men and women (p < 0.05).
CONCLUSION: Brachial FMD, rather than carotid IMT, was an independent predictor for cardiovascular events after adjusting for the extent of CAD. Moreover, impaired brachial endothelial function in women without significant CAD was associated with an increased risk of spontaneous cardiovascular events. Copyright 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 19006116      PMCID: PMC6652945          DOI: 10.1002/clc.20314

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  6 in total

1.  Endothelial function in postmenopausal women with nighttime systolic hypertension.

Authors:  Faye S Routledge; Alan L Hinderliter; Judith McFetridge-Durdle; James A Blumenthal; Nicola J Paine; Andrew Sherwood
Journal:  Menopause       Date:  2015-08       Impact factor: 2.953

2.  Soluble TNF and IL-6 receptors: indicators of vascular health in women without cardiovascular disease.

Authors:  Miriam Cortez-Cooper; Eric Meaders; Judith Stallings; Sara Haddow; Barbara Kraj; Gloria Sloan; Kevin K McCully; Joseph G Cannon
Journal:  Vasc Med       Date:  2013-10       Impact factor: 3.239

3.  Sex differences in the endothelial function of untreated hypertension.

Authors:  Faye S Routledge; Alan L Hinderliter; James A Blumenthal; Andrew Sherwood
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-03-05       Impact factor: 3.738

Review 4.  Imaging Subclinical Atherosclerosis: Where Do We Stand?

Authors:  Nikolaos Papageorgiou; Alexandros Briasoulis; Emmanuel Androulakis; Dimitris Tousoulis
Journal:  Curr Cardiol Rev       Date:  2017

5.  Cardiovascular risk factors have larger impact on endothelial function in self-reported healthy women than men in the HUNT3 Fitness study.

Authors:  Eli-Anne Skaug; Erik Madssen; Stian Thoresen Aspenes; Ulrik Wisløff; Øyvind Ellingsen
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

Review 6.  Prognostic Value of Flow-Mediated Vasodilation in Brachial Artery and Fingertip Artery for Cardiovascular Events: A Systematic Review and Meta-Analysis.

Authors:  Yasushi Matsuzawa; Taek-Geun Kwon; Ryan J Lennon; Lilach O Lerman; Amir Lerman
Journal:  J Am Heart Assoc       Date:  2015-11-13       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.